Q1 Earnings Estimate for McKesson Issued By Leerink Partnrs

McKesson Co. (NYSE:MCK - Free Report) - Equities researchers at Leerink Partnrs issued their Q1 2026 EPS estimates for McKesson in a note issued to investors on Wednesday, April 2nd. Leerink Partnrs analyst M. Cherny expects that the company will post earnings of $8.34 per share for the quarter. The consensus estimate for McKesson's current full-year earnings is $32.77 per share. Leerink Partnrs also issued estimates for McKesson's Q2 2026 earnings at $8.57 EPS, Q3 2026 earnings at $9.46 EPS, Q4 2026 earnings at $10.38 EPS and FY2026 earnings at $36.75 EPS.

Other analysts have also recently issued reports about the stock. Mizuho increased their target price on shares of McKesson from $630.00 to $690.00 and gave the stock a "neutral" rating in a report on Thursday, April 3rd. StockNews.com cut shares of McKesson from a "strong-buy" rating to a "buy" rating in a research report on Friday, February 14th. Wells Fargo & Company boosted their price objective on McKesson from $641.00 to $691.00 and gave the stock an "equal weight" rating in a report on Friday, March 14th. Evercore ISI upped their price target on McKesson from $650.00 to $675.00 and gave the company an "outperform" rating in a research report on Thursday, February 6th. Finally, Morgan Stanley boosted their target price on McKesson from $642.00 to $745.00 and gave the company an "overweight" rating in a research note on Wednesday, April 2nd. Two analysts have rated the stock with a hold rating, thirteen have given a buy rating and one has assigned a strong buy rating to the company's stock. According to MarketBeat, the company has a consensus rating of "Moderate Buy" and an average target price of $661.00.

Remove Ads

McKesson Trading Down 0.1 %

NYSE MCK traded down $0.62 during mid-day trading on Thursday, reaching $661.35. 592,850 shares of the company's stock traded hands, compared to its average volume of 864,467. The company has a market cap of $82.88 billion, a price-to-earnings ratio of 30.24, a P/E/G ratio of 1.29 and a beta of 0.49. McKesson has a 1-year low of $464.42 and a 1-year high of $728.32. The company has a fifty day simple moving average of $634.52 and a 200-day simple moving average of $587.00.

McKesson (NYSE:MCK - Get Free Report) last issued its quarterly earnings data on Wednesday, February 5th. The company reported $8.03 earnings per share (EPS) for the quarter, missing the consensus estimate of $8.60 by ($0.57). McKesson had a net margin of 0.82% and a negative return on equity of 181.26%.

Institutional Inflows and Outflows

Large investors have recently modified their holdings of the company. Capital A Wealth Management LLC acquired a new stake in McKesson during the fourth quarter valued at approximately $26,000. Millstone Evans Group LLC bought a new stake in shares of McKesson in the 4th quarter worth about $28,000. Synergy Asset Management LLC bought a new position in McKesson during the 4th quarter valued at about $32,000. Crews Bank & Trust bought a new stake in McKesson during the fourth quarter worth about $33,000. Finally, Atala Financial Inc acquired a new stake in shares of McKesson during the fourth quarter worth approximately $34,000. 85.07% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at McKesson

In related news, CEO Brian S. Tyler sold 8,961 shares of McKesson stock in a transaction dated Friday, February 21st. The stock was sold at an average price of $597.99, for a total transaction of $5,358,588.39. Following the sale, the chief executive officer now directly owns 60,664 shares of the company's stock, valued at $36,276,465.36. This trade represents a 12.87 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP Leann B. Smith sold 188 shares of the firm's stock in a transaction that occurred on Wednesday, February 12th. The stock was sold at an average price of $609.59, for a total value of $114,602.92. Following the completion of the sale, the executive vice president now owns 1,051 shares of the company's stock, valued at $640,679.09. This represents a 15.17 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 18,110 shares of company stock worth $10,855,706 over the last three months. 0.11% of the stock is currently owned by insiders.

McKesson Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, April 1st. Shareholders of record on Monday, March 3rd were given a $0.71 dividend. This represents a $2.84 annualized dividend and a yield of 0.43%. The ex-dividend date was Monday, March 3rd. McKesson's dividend payout ratio is currently 13.00%.

About McKesson

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.